The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work‐up in cystic fibrosis patients

Archive ouverte

Braun, Camille | Reix, Philippe | Durieu, Isabelle | Nove-Josserand, Raphaele | Durupt, Stéphane | Ohlmann, Camille | Mainguy, Catherine | Nicolas, Jean‐françois | Nosbaum, Audrey | Jubin, Virginie

Edité par CCSD ; Wiley -

International audience. Abstract Cystic fibrosis (CF) patients receive many antibiotic treatments for recurrent respiratory infections and frequently report antibiotic hypersensitivity reactions (HSRs). In this retrospective study, medical records of CF patients were reviewed to clarify the clinical features, the culprit antibiotics, and the prevalence of antibiotic HSRs in the CF population. From 601 CF patients, 95 suspected antibiotic HSRs occurred in 60 patients (prevalence of 10.0%). β‐Lactams were the most common inducers, but cotrimoxazole was also frequently involved. Seventy‐six of 95 suspected HSRs were assessed by allergy workup including skin tests (43/76 reactions) and/or drug reintroduction as a full course of the culprit antibiotic (73 of 76 reactions). From the 43 suspected HSRs that were skin‐tested, only three had positive skin tests and were not subjected to drug readministration. All the other 73 suspected HSRs received a full course of the culprit antibiotic: HSR symptoms recurred in 10 of 73 cases and therefore were considered as confirmed antibiotic HSRs; for the remaining 63 suspected HSRs that did not relapse after drug readministration, the diagnosis of antibiotic HSRs was excluded. In summary, 13 of 76 suspected HSRs were confirmed as antibiotic HSRs. The prevalence of suspected and confirmed antibiotic HSRs in CF patients appears similar to that reported in the general population. Of note, most of the antibiotic suspected HSRs are not confirmed after allergology workup. A complete allergy workup appears therefore crucial to make a correct diagnosis and to avoid unnecessary contraindication of major antibiotics.

Consulter en ligne

Suggestions

Du même auteur

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

Archive ouverte | Burgel, Pierre-Régis | CCSD

International audience

Real-life acute lung function changes after lumacaftor/ivacaftor first administration in pediatric patients with cystic fibrosis

Archive ouverte | Labaste, Aurélie | CCSD

International audience. The combination of lumacaftor and ivacaftor (LUM/IVA) has been reported to induce a mean acute absolute drop of -4.1% predicted forced expiratory volume in 1 s (FEV 1 ) after a unique adminis...

Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis

Archive ouverte | Reverchon, Jérémy | CCSD

International audience. Therapeutic drug monitoring (TDM) of tobramycin is widely performed in patients with cystic fibrosis (CF), but little is known about the value of model-informed precision dosing (MIPD) in thi...

Chargement des enrichissements...